4 unknown, 1 completed, 1 recruiting, 1 terminated. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 4, Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Preterm Birth: new trials by email Literature Review of Preterm Birth trials Research Report on Preterm Birth
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) Daily aspirin (ASA), Split dose aspirin (ASA) - Preterm Birth, Preeclampsia | Phase 1 / Phase 2 | Recruiting | Thomas Jefferson University | 400 | 2025-06-26 | 2025-07-17 |
| Antenatal Dexamethasone for Late Preterm Deliveries Dexamethasone - Respiratory Distress of Newborn, Preterm Birth | Phase 1 | Unknown | Chulalongkorn University | 294 | 2023-08-25 | 2024-02-08 |
| Preventing Preterm Birth With a Negative Pressure Cervical Cup: a Feasibility Study Hannah Cervical Cup (2 mm Delta), Hannah Cervical Cup (4 mm Delta), Hannah Cervical Cup (6 mm Delta) - Preterm Birth, Cervical Incompetence | Phase 1 | Unknown | Galena Innovations, LLC | 40 | 2023-04-01 | 2022-08-26 |
| Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS Alveofact, Budesonide - Neonatal Respiratory Distress Syndrome, Inflammatory Response | Phase 1 | Unknown | Ain Shams University | 60 | 2022-08-18 | 2024-04-16 |
| The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth LACTIN-V - Preterm Labor, Preterm Birth | Phase 1 | Unknown | Imperial College London | 60 | 2019-09-16 | 2020-05-28 |
| India Dexamethasone and Betamethasone Dexamethasone 4 mg/ml, Betamethasone 4 mg/ml, Celestone Soluspan 6Mg/Ml Suspension for Injection - Preterm Birth, Antenatal Corticosteroids | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 48 | 2018-09-20 | 2020-07-14 |
| Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth 17-Hydroxyprogesterone caproate 250mg or 500 mg., Safety study of 500 mg dose. - Preterm Birth | Phase 1 / Phase 2 | Terminated | Steve N. Caritis, MD | 159 | 2018-02-12 | 2023-10-23 |
Premature Birth (7) · Uterine Cervical Incompetence (2) · Dyspnea (1) · Infections (1) · Obstetric Labor, Premature (1) · Pre-Eclampsia (1) · Preterm Premature Rupture of the Membranes (1) · Pulmonary Atelectasis (1) · Respiratory Distress Syndrome, Newborn (1)
Female Urogenital Diseases and Pregnancy Complications (7) · Obstetric Labor Complications (7) · Pregnancy Complications (7) · Urogenital Diseases (7) · Obstetric Labor, Premature (6) · Abortion, Habitual (2) · Abortion, Spontaneous (2) · Female Urogenital Diseases (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Lung Diseases (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Uterine Cervical Diseases (2) · Uterine Diseases (2)
Dexamethasone (2) · APF protein, Lactobacillus crispatus (1) · Betamethasone (1) · Budesonide (1) · Injections (1) · SF-RI 1, bovine surfactant preparation (1) · Safety (1) · Suspensions (1) · betamethasone acetate phosphate (1)
Ain Shams University (1) · Children's Hospital Medical Center, Cincinnati (1) · Chulalongkorn University (1) · Galena Innovations, LLC (1) · Imperial College London (1) · Steve N. Caritis, MD (1) · Thomas Jefferson University (1)
United States (3) · Egypt (1) · India (1) · United Kingdom (1) · Vietnam (1)
Alan Jobe, MD, Ph.D (1) · Ashley C Crafton (1) · Phillip Bennett, BSc PhD MD (1) · Steve N Caritis, MD (1)
PMID 37100349, PMID 41452963, PMID 41872545
R01HD112076 (1), U54HD047905 (1)